How the BioLife Solutions Master File Letter Request Process Works for CryoStor® and HypoThermosol® FRS

Cross-Referencing BioLife Master Files CryoStor and HypoThermosol FRS (HTS-FRS) are critical components in many customer cell and gene therapy (CGT) and regenerative medicine processes. Although they are not regulated medical products—meaning they are not classified as drugs, medical devices, or marketed/registered as excipients—they serve a critical role as ancillary/raw materials in cell-based manufacturing processes. BioLife […]

How Does a Water-Free Automated Thawing System Improve Your Cryopreservation Process?

ThawSTAR Water-free Thawing System

Cryopreservation has come a long way… Over the past 50 years, advances in biopreservation techniques have enabled industry-wide progress in a range of fields including cell biology research, drug discovery, biobanking, assisted reproduction, and even plant and animal conservation, with the fields of cellular therapy and regenerative medicine seeing the greatest expansion recently. As these […]

Overcoming Cryopreservation Challenges

Cryopreservation Best Practices

Navigating the Challenges of Cryopreservation in Cell-Based Research Biopreservation, and specifically cryopreservation, is critical for maintaining the viability of cells long-term throughout storage and research. Recently, BioLife Solutions partnered with Cell and Gene Therapy Insights to produce a poster that highlights many of the challenges researchers face, balanced with Biopreservation Best Practice suggestions. To receive […]

Journal Articles Citing CryoStor CS10® Recently Added to BioLife Solutions’ Evidence Library

blue 3D T-Cell Image

Multiple Uses for CryoStor in Cell Manufacturing Journal articles recently added to BioLife Solutions’ Evidence Library illustrate several stages during the cell manufacturing process for which CryoStor CS10® cryopreservation solution is applicable. The three articles that follow include several different cell types cryopreserved in CryoStor CS10. An expanded list of cell types biopreserved in BioLife […]

Cellular Therapies for COVID-19 Highlighted During ISCT Paris 2020 (VIRTUAL)

T-cell graphic

The global impact of COVID-19 on our lives has been profound at virtually every level. Personally, professionally, politically, and economically, the pandemic impacts our lives, our relationships, and how we conduct business. We begin and end the day with the latest news on SARS-CoV-2, and up-to-the-minute COVID-19 data. In between, we must surmount any number […]

Joining Forces!

T-cell graphic

BioLife Solutions issued a press release August 8, 2019, announcing the execution of a share exchange agreement to purchase the remaining 56% of shares of SAVSU Technologies that BioLife did not previously own. BioLife’s relationship with Savsu spans six years, during the development and growth of the evo® Cold Chain 2.0™ system, encompassing evo® hardware […]

Could not attend? BioLife Solutions’ Posters Presented During ISCT 2019 International Meeting in Melbourne

T-cell graphic

Posters presenting data for T-cells cryopreserved in CryoStor® cryopreservation solution, authored by BioLife Solutions’ Alireza Abazari, Ph.D., Scientific Applications Director and Aby J. Mathew, Ph.D., Senior Vice President & Chief Technology Officer, were featured during the International Society for Cell & Gene Therapy meeting in Melbourne, Australia, May 29 – June 1, 2019. View the […]

JOIN OUR BIOPRESERVATION BEST PRACTICES WEBINAR!

T-cell graphic

Implementation of Biopreservation Best Practices to Address a Critical Component of Cell & Gene Therapy Manufacturing Hosted by Cell and Gene Therapy Insights Implementation of best practices in formulation can directly address multiple process bottlenecks including: GMP compliance, minimizing freezing damage, support stability during storage and against transient warming events, support post-thaw stability, and excipient […]

This website uses cookies to ensure you get the best experience on our website.